Immuneering Corporation
IMRX
$5.02
$0.173.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 468.76% | 336.89% | 378.16% | 349.22% | -55.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 490.57% | 101.47% | -0.82% | -66.56% | -65.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 469.84% | 322.47% | 345.21% | 314.59% | -56.47% |
|
|
|||||
| Total Current Assets | 469.84% | 322.47% | 345.21% | 314.59% | -56.47% |
| Net Property, Plant & Equipment | -10.01% | -10.00% | -11.05% | -13.11% | -12.80% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -8.73% | -8.54% | -8.36% | -8.16% | -8.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -66.96% | -65.70% | -78.11% | -51.28% | -31.46% |
| Total Assets | 404.43% | 323.84% | 340.08% | 251.61% | -48.04% |
|
|
|||||
| Total Accounts Payable | 41.01% | 10.88% | -21.23% | -17.63% | -8.66% |
| Total Accrued Expenses | -9.30% | -9.58% | 57.70% | 62.93% | 20.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.89% | 17.11% | 17.35% | 17.59% | 17.82% |
| Total Finance Division Other Current Liabilities | 2.29% | -21.77% | 24.73% | 34.17% | 132.48% |
| Total Other Current Liabilities | 2.29% | -21.77% | 24.73% | 34.17% | 132.48% |
| Total Current Liabilities | 8.40% | -2.62% | 34.25% | 37.94% | 10.41% |
|
|
|||||
| Total Current Liabilities | 8.40% | -2.62% | 34.25% | 37.94% | 10.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.81% | -11.07% | -10.38% | -9.75% | -9.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.80% | -6.19% | 19.18% | 20.70% | 3.14% |
|
|
|||||
| Common Stock & APIC | 77.63% | 78.01% | 87.71% | 88.18% | 9.60% |
| Retained Earnings | -22.57% | -22.75% | -24.98% | -30.30% | -32.42% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 559.16% | 393.56% | 427.92% | 294.96% | -56.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 559.16% | 393.56% | 427.92% | 294.96% | -56.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 559.16% | 393.56% | 427.92% | 294.96% | -56.36% |
|
|
|||||